Navigation Links
Mayo Clinic Proceedings reviews deep brain stimulation to treat psychiatric diseases
Date:6/29/2009

hronic and relapsing illness, is approximately 17 percent, affecting almost 1 in 5 persons.

Medications and psychiatric therapy can effectively treat many patients with major depression; however, up to 20 percent of these patients fail to respond to these non-surgical therapeutic interventions.

"DBS is not a miracle cure and should not be used to treat all depression," says Dr. Lee. "It should be reserved for those patients who have treatment-resistant depression and approved by a multi-disciplinary team." Ongoing advances in DBS technologies represent an important new field that could greatly advance the understanding of psychiatric neurobiology, according to the review.


'/>"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
2. OpusClinicalSuite(R) Achieves 08 CCHIT Certification as Inpatient EHR
3. Clinical Study Data Indicates that Celliant Reduces Pain
4. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
5. Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery
6. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
7. Heritage Summit HealthCare Inc. Contracts with Mayo Clinic for Workers Compensation Care
8. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
9. Living Cell Technologies Diabetes Clinical Trial Authorized by New Zealand Government
10. Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals
11. Caregivers at Alameda County Clinic to Strike Over Bad-Faith Bargaining by Clinic Management
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 1Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 2Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 3Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2Insulet Corporation to Present at Upcoming Investor Conferences 53953 1Insulet Corporation to Present at Upcoming Investor Conferences 53953 2